RESUMEN
A 19-year-old woman with skeletal Class III malocclusion, paranasal depression, and a low mandibular plane angle was treated with orthodontics and orthognathic surgery. Dental decompensation and protraction of maxillary right third molar to replace maxillary right second molar were performed before surgery. Clockwise rotation of maxillo-mandibular complex was applied by Le Fort I osteotomy and bilateral sagittal split osteotomies to achieve facial balance. The active treatment period was 12 months. The stable occlusion and skeletal relationship were observed after a 10-month follow-up period.
Asunto(s)
Maloclusión de Angle Clase III/cirugía , Mandíbula/cirugía , Maxilar/cirugía , Procedimientos Quirúrgicos Ortognáticos/métodos , Cefalometría/métodos , Femenino , Estudios de Seguimiento , Humanos , Maloclusión de Angle Clase III/terapia , Osteotomía Le Fort/métodos , Osteotomía Sagital de Rama Mandibular/métodos , Sobremordida/cirugía , Sobremordida/terapia , Planificación de Atención al Paciente , Prognatismo/cirugía , Prognatismo/terapia , Rotación , Técnicas de Movimiento Dental/métodos , Resultado del Tratamiento , Dimensión Vertical , Adulto JovenRESUMEN
BACKGROUND: Most patients treated with orthognathic surgery for facial asymmetry would value improvement in residual soft-tissue asymmetry. Autologous fat transfer is widely used to augment facial soft tissue. The authors assessed the effect of combining orthognathic surgery with autologous fat transfer for treating patients with facial asymmetry. METHODS: In this retrospective study, 15 consecutive adults underwent combined orthognathic surgery and autologous fat transfer between January of 2013 and December of 2015. Lower facial profile symmetry was assessed using postoperative standard frontal photographs. RESULTS: Lower facial symmetry was much improved by combining orthognathic surgery and autologous fat injection. CONCLUSION: The combined use of orthognathic surgery and autologous fat transfer is a promising technique for improving facial symmetry in patients with facial asymmetry. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.